Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc., 54919-54920 [2013-21750]

Agencies

• Drug Enforcement Administration
• Department of Justice

[Federal Register Volume 78, Number 173 (Friday, September 6, 2013)]
[Notices]
[Pages 54919-54920]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-21750]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Alltech Associates, Inc.

    By Notice dated May 14, 2013 and published in the Federal Register 
on May 22, 2013, 78 FR 30331, Alltech Associates, Inc., 2051 Waukegan 
Road, Deerfield, Illinois 60015, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).........................................          I
N-Ethylamphetamine (1475)....................................          I
N,N-Dimethylamphetamine (1480)...............................          I
4-Methylaminorex (cis isomer) (1590).........................          I
Alpha-ethyltryptamine (7249).................................          I
Lysergic acid diethylamide (7315)............................          I
2C-T-7 (2,5-Dimethoxy-4-(n)-Propylthiophenethylamine) (7348).          I
Tetrahydrocannabinols (7370).................................          I
Mescaline (7381).............................................          I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine) (7385)          I
4-Bromo-2,5-dimethoxyamphetamine (7391)......................          I
4-Bromo-2,5-dimethoxyphenethylamine (7392)...................          I

[[Page 54920]]

 
4-Methyl-2,5-dimethoxyamphetamine (7395).....................          I
2,5-Dimethoxyamphetamine (7396)..............................          I
2,5-Dimethoxy-4-ethylamphetamine (7399)......................          I
3,4-Methylenedioxyamphetamine (7400).........................          I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...............          I
3,4-Methylenedioxy-N-ethylamphetamine (7404).................          I
3,4-Methylenedioxymethamphetamine (7405).....................          I
4-Methoxyamphetamine (7411)..................................          I
5-Methoxy-N-N-dimethyltryptamine (7431)......................          I
Alpha-methyltryptamine (7432)................................          I
Bufotenine (7433)............................................          I
Diethyltryptamine (7434).....................................          I
Dimethyltryptamine (7435)....................................          I
Psilocybin (7437)............................................          I
Psilocyn (7438)..............................................          I
5-Methoxy-N,N-diisopropyltryptamine (7439)...................          I
N-Ethyl-1-phenylcyclohexylamine (7455).......................          I
1-(1-Phenylcyclohexyl)pyrrolidine (7458).....................          I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).................          I
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) (7509)......          I
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) (7517)..............          I
2C-1(2-(4-lodo-2,5-dimethoxyphenyl)ethanamine) (7518)........          I
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (7519).....          I
2C-T-4 (2-4-isopropylthio)-2,5-dimethoxyphenyl ethanamine)             I
 (7532)......................................................
Dihydromorphine (9145).......................................          I
Heroin (9200)................................................          I
Normorphine (9313)...........................................          I
Methamphetamine (1105).......................................         II
1-Phenylcyclohexylamine (7460)...............................         II
Phencyclidine (7471).........................................         II
Phenylacetone (8501).........................................         II
1-Piperidinocyclohexanecarbonitrile (8603)...................         II
Cocaine (9041)...............................................         II
Codeine (9050)...............................................         II
Dihydrocodeine (9120)........................................         II
Ecgonine (9180)..............................................         II
Meperidine intermediate-B (9233).............................         II
Noroxymorphone (9668)........................................         II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Alltech Associates, Inc., to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Alltech Associates, Inc., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: August 29, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-21750 Filed 9-5-13; 8:45 am]
BILLING CODE 4410-09-P